Post by : Badri Ariffin

Abu Dhabi is making significant strides in bolstering its public health infrastructure with the expansion of the Reference Laboratory for Infectious Diseases (RLID-AD). This initiative greatly improves the emirate’s capacity to identify, monitor, and manage infectious diseases, thereby elevating its preparedness for health crises.

Situated at SEHA Sheikh Khalifa Medical City, the upgraded facility focuses on advanced molecular diagnostics and high-level infectious disease testing. Enhanced workflows streamline every aspect from sample intake to genetic analysis, enabling the lab to handle a greater volume of tests without compromising quality and biosafety protocols. As a result, diagnoses are quicker, and disease surveillance is more comprehensive, particularly during outbreaks or potential pandemics.

A standout feature of this enhancement is the introduction of a BSL-3 mobile lab unit. This specialized facility allows for immediate testing and analysis in outbreak zones, minimizing response times and facilitating rapid containment efforts. Built to meet international standards, this mobile lab significantly upgrades Abu Dhabi’s biosafety measures and adds an adaptable element to its epidemic preparedness plan.

Managed by PureLab, a division of the PureHealth group, the facility showcases collaboration between public health officials and healthcare providers. Its role extends to both national and international health monitoring, recognized by the World Health Organization as a National Influenza Centre. The lab conducts vital testing not only for influenza but also for measles, rubella, and various other infectious agents.

Furthermore, the facility’s team is composed of skilled professionals, with over half being UAE nationals. Their expertise underscores Abu Dhabi’s commitment to nurturing local talent in critical areas of public health and laboratory sciences.

In summary, the expansion of the Reference Laboratory for Infectious Diseases is a vital step in line with Abu Dhabi’s vision for a resilient and proactive health system. By investing in cutting-edge diagnostics, mobile biosafety options, and local expertise, the emirate further solidifies its capability to safeguard public health and effectively tackle emerging infectious disease challenges.

#Global News